Sacroiliac Joint Fusion
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.126 alerts
Get alerted when Policy CP.MP.126 changes without checking for updates manually.
Monitor payer policy activity
Clinical coverage criteria and coding guidance for open and minimally invasive sacroiliac joint (SIJ) fusion for members of Arizona Complete Health (Centene-affiliated plans). Applies to providers requesting authorization for SIJ fusion procedures.
New criteria added for minimally invasive SIJ fusion.
Criteria added specifying that procedure will be performed using the lateral transarticular approach.
Added criterion IV stating implants not placed across the joint (non-transfixing) are not supported due to unproven long-term safety/effectiveness.
Coverage Criteria for Sacroiliac Joint (SIJ) Fusion
Open SIJ fusion — medically necessary indications
Open SIJ fusion is medically necessary for ANY of the following:
Minimally invasive SIJ fusion — covered when ALL criteria met
Minimally invasive SIJ fusion is medically necessary when ALL of the following are met:
Not proven/limited indications
Long-term safety and effectiveness have not been proven for other indications:
Implant limitations
Covered only when transfixing implants placed across the joint are used:
SIJ fusion is not supported for indications beyond those explicitly listed in this policy. Specifically, treatment of mechanical or axial low back pain, radicular pain syndromes, sacral insufficiency fractures, and pelvic girdle pain is considered unproven due to limited clinical evidence and therefore is excluded from coverage under this policy.
Coverage determinations are made in the context of the member's specific plan. This clinical policy is intended to guide medical necessity determinations but does not replace the member's coverage documents. All decisions remain subject to the terms, conditions, exclusions and limitations of the member's evidence of coverage, certificate of coverage, policy or contract of insurance, and applicable state and federal requirements.
The policy does not support SIJ fusion using implants that are not placed across the joint. In other words, devices that do not transfix the sacroiliac joint (for example, certain intra-articular allografts or nonmetallic implants placed without transfixation) are considered unsupported because current evidence does not demonstrate their long-term safety or effectiveness.
Coding Guidance
| 27279 | Arthrodesis, sacroiliac joint, percutaneous or minimally invasive (indirect visualization), with image guidance, includes obtaining bone graft when performed, and placement of transfixation device. |
| 27280 | Arthrodesis, sacroiliac joint, open, includes obtaining bone graft, including instrumentation, when performed |
| 27278 | Arthrodesis, sacroiliac joint, percutaneous, with image guidance, including placement of intra-articular implant(s) (eg, bone allograft(s), synthetic device(s)), without placement of transfixation device. |
| 0775T | Code noted in revisions as removed/deleted from 'do not support' table (historical mention). |
| 0775T | deleted code (removed from 'Codes that do not support coverage criteria') |
Provider Actions, Authorization, and Documentation Requirements
Prior Authorization Required
Prior authorization is required for sacroiliac joint (SIJ) fusion procedures. Requests must follow the Health Plan's prior authorization procedures and be approved before the procedure is scheduled.
Authorization Documentation Requirements
Authorization requests must include documentation demonstrating that all clinical criteria are met. Submit complete medical records, including conservative therapy documentation, diagnostic testing, imaging, and procedure notes as applicable.
- Documentation of at least six months of conservative therapy, including medication optimization (or contraindication), activity modification, and at least 4–6 weeks of active therapeutic exercise targeted to lumbar spine, pelvis, SIJ and hip (or documentation of inability to tolerate)
- Clinical notes documenting pain consistent with SIJ pain (non-radiating, typically unilateral, caudal to L5) and interference with activities of daily living
- Physical exam findings: localized posterior SIJ tenderness and results of at least three positive provocative tests
- Imaging reports (within 6 months): plain radiographs, CT or MRI of SIJ, plain pelvic radiographs, and CT/MRI of the lumbar spine as indicated to exclude alternative diagnoses
- Documentation of at least 75% pain reduction after image-guided, contrast-enhanced diagnostic SIJ injection on two separate occasions
- Documentation of failure of at least one therapeutic intra-articular SIJ corticosteroid injection unless contraindicated
- Planned surgical approach (lateral transarticular) and device/implant details demonstrating transfixing implant placement when applicable
Denial Triggers for SIJ Fusion
Requests may be denied if required clinical criteria or documentation are not met. Denials may also occur when the indication is for an unproven or non-covered use.
- Less than six months of documented conservative therapy
- Absence of documented ≥75% pain relief from diagnostic SIJ injections on two occasions
- No documentation of at least one failed therapeutic intra-articular SIJ injection (unless contraindicated)
- Missing or outdated imaging that does not exclude alternative diagnoses (tumor, infection, fracture, inflammatory arthropathy, or concomitant hip pathology)
- Clinical presentation inconsistent with SIJ pain (e.g., diffuse or generalized pain, fibromyalgia, somatoform disorder) or lack of localized posterior SIJ tenderness and positive provocative tests
- Use of implants that do not transfix the joint (e.g., intra-articular implants such as bone allograft or synthetic devices without transfixation) for indications covered only when transfixing implants are used
- Procedure performed via an approach other than the required lateral transarticular approach when that is a criterion
Denial Risk and Administrative Considerations
Coverage decisions are subject to the member's benefit documents, exclusions, limitations, and applicable Health Plan administrative policies. The Health Plan may change, amend, or withdraw this policy; effective dates are determined by the Health Plan.
- Authorization and payment are not guaranteed solely by meeting clinical criteria; benefits, exclusions, and member-specific coverage apply
- Effective date of this clinical policy is determined by the Health Plan; verify authorization timing against the plan's effective date
- Providers remain responsible for exercising professional medical judgment and for the medical care of members/enrollees
Definitions
Background
The sacroiliac joint (SIJ) is a recognized source of chronic low back and buttock pain in a substantial subset of patients. SIJ fusion — performed either via an open technique or by minimally invasive approaches (commonly using a lateral transarticular technique with implants that transfix the joint) — is a surgical option when conservative measures fail or when specific clinical situations exist (for example, pelvic ring trauma, tumor resection adjuncts, infection, or when included as part of multi-segment spinal constructs).
Evidence supports that certain transfixing implants can improve pain and function compared with non-surgical management in appropriately selected patients; however, long-term effectiveness and comparative data across different devices remain limited, and some indications lack sufficient evidence to support fusion.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.